|Scientific Subdivisions | The Journal of Molecular Diagnostics
Contact AMP | Sign In | Join / Renew | Go To CHAMP
AMP 2014 Annual Meeting
AMP CELEBRATES 20 YEARS!
November 13 -15, 2014
Corporate Workshop Day & Gala, November 12, 2014
Gaylord National Resort & Convention Center
National Harbor, MD (just outside of Washington, DC)
The current focus for the Infectious Diseases Division of the Clinical Practice Committee is to work towards the normalization of quantitative nucleic acid amplification testing for analytes such as cytomegalovirus (CMV), Epstein-Barr virus (EBV) and BK virus, beginning with CMV.
CMV Working Group
The CMV Working Group is comprised of 64 AMP members with a uniform interest in standardizing CMV quantitation by PCR. This group was formed in the fall of 2003 under the leadership of Dr. Daynna Wolff. In 2004, Dr. Wolff, with the assistance of Dr. Paul Neuwald, coordinated a multicenter analysis which demonstrated that laboratories across the country using a wide variety of platforms performed similarly in terms of relative quantification from sample to sample. However, there was disparity in terms of absolute value.Â The results of this project were presented at the 2004 Annual Meeting and are available in the AMP Web Library. The current focus of the group is to work with the National Institutes of Standards and Technologies (NIST) for the formation of a standard unit for CMV PCR, to which all labs can normalize their system.
For more information, contact: Kathleen Stellrecht, PhD